TOPEKA – (August 3, 2011) – Kansas Attorney General Derek Schmidt today announced that Kansas has received $701,858 as part of a $40.75 million multistate settlement with GlaxoSmithKline and SB Pharmco Puerto Rico, Inc. The agreement settles allegations of substandard manufacturing processes which produced tainted drugs.
“Consumers expect medications prescribed by their doctors to be effective and safe,” Schmidt said. “This settlement holds drug manufacturers accountable for providing safe, reliable products.”
The complaint alleged that GlaxoSmithKline and SB Pharmco engaged in unfair and deceptive practices in the manufacturing and distribution of certain batches of the drugs Paxil CR, Kyrtil, Bactroban and Avandamet. The facility where these batches of drugs originated allegedly used substandard manufacturing processes to produce the drugs. The plant has been closed since 2009.
The affected batches of drugs have since been recalled, and are now past their expiration date. If consumers have concerns about the safety of their medications, they are encouraged to consult with a physician.